Prot: BI 695501 versus Humira® in Patients with Active Crohn’s Disease: A Randomized, Double-Blind, Multicenter, Parallel Group, Non-Inferiority Trial Comparing Efficacy, Endoscopic Improvement, Safety, and Immunogenicity

Project: Research project

Project Details

StatusFinished
Effective start/end date6/30/17 → 6/30/20

Funding

  • Quintiles, Inc. (Prot: BI 695501 // Prot: BI 695501)
  • Boehringer Ingelheim Pharmaceuticals, Inc. (Prot: BI 695501 // Prot: BI 695501)